In recent years, the use of Artificial Intelligence has revolutionized many industries, including the medical field. And now, OXOS Medical, an x-ray diagnostics company, is leveraging AI to make a significant impact in the world of medical imaging. OXOS is introducing a new generation of x-ray equipment that reduces radiation exposure by 80% while improving … Continued
Co-led by Parkway Venture Capital and Intel Capital, OXOS will leverage funds to expand into clinical, mobile, and home care settings across mature and emerging markets Atlanta, GA, April 5, 2023 – OXOS Medical, the MedTech innovator developing simple and safe X-ray solutions, announced a $23 million Series A funding from Parkway Venture Capital and … Continued
Since its inception in the early 1990s, Intel Capital has been investing in the future of semiconductor process technology. In the last 10 years alone, Intel Capital has invested ~$5 billion in over 125 companies in the semiconductor process technology space and has been ranked the #1 investor in semiconductor manufacturing (source: Pitchbook). Investments have ranged … Continued
Capital to accelerate EUV Tech product roadmap in support of leading-edge semiconductor lithography Martinez, CA, March 1, 2023 – EUV Tech, a global leader in the production of metrology equipment to enable leading-edge semiconductor manufacturing using extreme ultraviolet lithography (EUVL), secured Series A funding led by Intel Capital. EUV Tech will use the capital to … Continued
The funding will enable the shipping of the first systems to customers Zürich, Switzerland, February 16, 2023 — UNISERS, a Swiss semiconductor metrology company that identifies invisible contamination-caused defects in semiconductor materials, raised $14M in Seed funding led by Intel Capital, with participation from M Ventures, RSBG Ventures and Swisscom Ventures. UNISERS is on a … Continued
Many of us have a parent, a grandparent or a close friend who requires five or more medications to treat one or more conditions, defining them as polypharmacy patients. Studies indicate that polypharmacy is common in 37% of all medication classes.* Most patients over 65 years experience some degree of polypharmacy with many experiencing major polypharmacy. … Continued
The AI-powered platform automates medication management to help prevent adverse drug reactions: the fourth leading cause of death in the US Los Angeles, CA, February 14, 2023 — MDI Health, an AI-powered platform that automates the optimization of personalized medication treatment, at scale, has raised $20 million in Series A funding led by Intel Capital … Continued
Fueled by capital from NEA, creator of novel manufacturing technology scales high resolution, sustainable, and cost-effective metal parts production SAN DIEGO, Calif., February 7, 2023 — Fabric8Labs, pioneer of electrochemical additive manufacturing, today announced the close of a $50M Series B investment round led by New Enterprise Associates (NEA), with participation from existing investors, including … Continued
Stop for a moment and think about the house you live in. The structure was built using an endless supply of materials manufactured by third parties. From the drywall, to the plumbing, to the electrical wiring, all the way down to the cement and rebar comprising the very foundation. It’s a complicated structure built from … Continued
Funding enables new capabilities for operationalizing continuous software modernization Miami, FL, February 7, 2023 — Moderne, the continuous software modernization company, is moving swiftly to address the unmet market need of automating code migration and remediation for large, composed software systems that are continually evolving and growing in complexity. Moderne announced $15 million in Series … Continued